⌘K

Home/Filings/4/0001171843-17-000583

4//SEC Filing

Anika Therapeutics, Inc. 4

Accession 0001171843-17-000583

$ANIKCIK 0000898437operating

View on SEC.gov Company Profile

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 4:05 PM ET

Size

5.4 KB

Accession

0001171843-17-000583

Insider Transaction Report

Form 4

Period: 2017-01-27

Anika Therapeutics, Inc.ANIK

Chief Tech. & Strategy Officer

Transactions

Award
Stock Option (Right to Buy)
2017-01-27+22,500→ 22,500 total
Exercise: $50.13Exp: 2027-01-27→ Common Stock (22,500 underlying)

Footnotes (1)

[F1]The stock options vest in three equal annual installments beginning January 27, 2018.

Documents

1 file

4
formfour.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Anika Therapeutics, Inc.

CIK 0000898437

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000898437

Filing Metadata

Form type: 4
Filed: Jan 30, 7:00 PM ET
Accepted: Jan 31, 4:05 PM ET
Size: 5.4 KB

View on SEC.gov